Ethan Menahem Shevach - Nanotechnology

Author Information

Ethan M. Shevach is a prominent researcher associated with the Laboratory of Immune System Biology at the National Institute of Allergy and Infectious Diseases, which is part of the National Institutes of Health in Bethesda, MD. His work primarily focuses on immunology, particularly the regulation and function of T cells within the immune system.

Research Contributions

Ethan M. Shevach has made significant contributions to the field of immunology, with a special emphasis on T regulatory cells (Tregs) and their role in immune homeostasis and disease. His research has explored various mechanisms through which Tregs influence immune responses, including their interaction with other immune cells and their role in conditions such as autoimmunity, cancer, and infectious diseases. Some of his notable studies have investigated the factors influencing T cell function and the potential therapeutic implications in enhancing immune responses against tumors and viral infections.

Aliases

Ethan M. Shevach is known by several aliases in academic publications, including Ethan M. Shevach, E. M. Shevach, and Ethan Menahem Shevach, among others. These variations are often attributed to different formatting styles in academic journals.

Publication and Citation Metrics

Metric	Value
Total Citations	60,310
H-Index	113
Number of Papers	617

Publications:

Control of Memory Phenotype T Lymphocyte Homeostasis: Role of Costimulation

DOI: 10.4049/jimmunol.2100653

Year: 2022

Abstract 1527: Integrated computational and experimental analysis identifies the mitochondrial uncoupling protein 2 (Ucp2) as a key regulator of T cell anti-tumor function

DOI: 10.1158/1538-7445.AM2021-1527

Year: 2021

IL-35 promotes CD4+Foxp3+ Tregs and inhibits atherosclerosis via maintaining CCR5-amplified Treg-suppressive mechanisms

DOI: 10.1172/jci.insight.152511

Year: 2021

T Follicular Regulatory Cell Suppression of T Follicular Helper Cell Function Is Context-Dependent in vitro

DOI: 10.3389/fimmu.2020.00637

Year: 2020

Cutting Edge: Inhibition of the Interaction of NK Inhibitory Receptors with MHC Class I Augments Antiviral and Antitumor Immunity

DOI: 10.4049/jimmunol.2000412

Year: 2020

Salt Sensing by Serum/Glucocorticoid-Regulated Kinase 1 Promotes Th17-like Inflammatory Adaptation of Foxp3+ Regulatory T Cells.

DOI: 10.1016/j.celrep.2020.01.002

Year: 2020

Type I IFN signaling in T regulatory cells modulates chemokine production and myeloid derived suppressor cells trafficking during EAE.

DOI: 10.1016/j.jaut.2020.102525

Year: 2020

Regulatory T cells: Master thieves of the immune system.

DOI: 10.1016/j.cellimm.2020.104160

Year: 2020

Control of regulatory T cell homeostasis.

DOI: 10.1016/j.coi.2020.07.001

Year: 2020

Corrigendum to "Selective deletion of Eos (Ikzf4) in T-regulatory cells leads to loss of suppressive function and development of systemic autoimmunity" [J. Autoimmun. 105C (2019) 102300].

DOI: 10.1016/j.jaut.2020.102544

Year: 2020

What are the advantages of CARS over other spectroscopic techniques?

What are the Applications of Nanotechnology in Wearables?

What is a Piezoelectric Transducer?

How Are Homogeneous Mixtures Created at the Nanoscale?

What Makes a Successful Nano Startup?

Why Are You Interested in This Position?

Why are Dynamic Studies Important?

What is a Transducer?

How to File a Nanotechnology Patent?

How are Electronic States Measured and Analyzed?

Partnered Content Networks

Relevant Topics